Chris O’Brien Lifehouse, a not-for-profit, comprehensive cancer hospital renowned for its commitment to advanced cancer care, is proud to announce that it has raised $120,000 in new funding. This significant financial boost reinforces the hospital’s mission to provide the highest quality care for patients with cancer, from early screening through to prevention, diagnosis, treatment, and ongoing wellness. Each year, Lifehouse treats over 57,000 patients from across Australia, leveraging the latest technology and a modern, purpose-built facility to address even the most rare and complex cancer cases. The funds will be used to further enhance the integrated services offered—ranging from surgery, chemotherapy, and radiation oncology to supportive care and evidence-based complementary therapies such as acupuncture, mindfulness, and exercise physiology. By investing in a comprehensive care model, Lifehouse ensures that every patient receives a holistic treatment program designed to address their unique needs, improving overall outcomes by as much as 5 to 15 percent, as recent research has shown.
Furthermore, the new funding will support multidisciplinary collaboration among surgeons, medical oncologists, radiation oncologists, psychologists, and researchers, ensuring patients benefit from tailored, peer-reviewed treatment plans. As the largest cancer clinical trial centre in NSW, Lifehouse continuously bridges the gap between cutting-edge research and clinical practice, making breakthroughs and lifesaving drugs more accessible to those in need. This infusion of funds not only strengthens the hospital’s research program but also underscores its commitment to building a future without cancer—a mission encapsulated in Prof. Chris O’Brien’s inspiring call to action.
.png&w=3840&q=75)
